(Q41475636)

1 October 2017

Ouabain-resistant non-small-cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP). (English)

1 reference

1 October 2017

T Ohmori

1

1 reference

1 October 2017

K Nishio

2

1 reference

1 October 2017

S Ohta

3

1 reference

1 October 2017

N Kubota

4

1 reference

1 October 2017

M Adachi

5

1 reference

1 October 2017

K Komiya

6

1 reference

1 October 2017

N Saijo

7

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

International Journal of Cancer

1 October 2017

1 reference

1 October 2017

57

1 reference

1 October 2017

111-116

1 reference

1 October 2017

1

1 reference

Determinants of drug response in a cisplatin-resistant human lung cancer cell line

1 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910570120

Cellular accumulation of the anticancer agent cisplatin: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910570120

Drugs five years later. Cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910570120

Reversal of Cisplatin Resistance with Amphotericin B in a Non-small Cell Lung Cancer Cell Line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910570120

The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910570120

Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910570120

21 January 2018

Identifiers

DOI

10.1002/IJC.2910570120

1 reference

1 October 2017

1 reference